Johnson & Johnson (JNJ) Property, Plant & Equipment (Net) (2009 - 2026)

Johnson & Johnson (JNJ) Property, Plant & Equipment (Net) (2009 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn 12.59 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn 26.54 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn 23.27 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn 5.69 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn 25.43 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn 8.22 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn 5.64 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn 19.40 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn 7.66 Bn
10 Novartis Ag 108.28 Bn 107.60 Bn - -

Historic Data

Download Data
DateValue
Mar 29, 2026 23.27 Bn
Mar 29, 2026 23.27 Bn
Dec 28, 2025 23.17 Bn
Dec 28, 2025 23.17 Bn
Sep 28, 2025 22.34 Bn
Sep 28, 2025 22.34 Bn
Jun 29, 2025 21.95 Bn
Jun 29, 2025 21.95 Bn
Mar 30, 2025 20.87 Bn
Mar 30, 2025 20.87 Bn
Dec 29, 2024 20.52 Bn
Dec 29, 2024 20.52 Bn
Sep 29, 2024 20.48 Bn
Sep 29, 2024 20.48 Bn
Jun 30, 2024 19.75 Bn
Jun 30, 2024 19.75 Bn
Mar 31, 2024 19.63 Bn
Mar 31, 2024 19.63 Bn
Dec 31, 2023 19.90 Bn
Dec 31, 2023 19.90 Bn